Chris R.

Chris RINSCH is the President, Co-Founder, and Board Member at Timeline®, a Swiss longevity company focused on science-first products to optimize cellular health. Additionally, Chris is the CEO, Co-Founder, and Board Member at Vandria SA, a Swiss biotech company specializing in therapies for aging-related diseases. With a background in investment management and product development, Chris holds a MBA from INSEAD, a MS in Biomedical Engineering from UT Southwestern Medical Center, a BS in Engineering from Harvey Mudd College, and a PhD in Cell and Molecular Biology and Gene Therapy from the University of Lausanne.